| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.07 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.13 | 0.08 |